Antibody Responses to Helicobacter pylori and Risk of Developing Colorectal Cancer in a European Cohort.
Julia ButtMazda JenabMichael PawlitaAnne TjønnelandCecilie KyroMarie-Christine Boutron-RuaultFranck CarbonnelCatherine DongRudolf KaaksTilman KühnHeiner BoeingMatthias Bernd SchulzeAntonia TrichopoulouAnna KarakatsaniCarlo La VecchiaDomenico PalliClaudia AgnoliRosario TuminoCarlotta SacerdoteSalvatore PanicoBas Bueno-de-MesquitaRoel VermeulenInger Torhild GramElisabete WeiderpassKristin Benjaminsen BorchJose Ramón QuirósAntonio AgudoMiguel Rodríguez BarrancoCarmen SantiusteEva ArdanazBethany Van GuelpenSophia HarlidLiher ImazAurora Perez-CornagoMarc J GunterSemi ZouiouichJin Young ParkElio RiboliAmanda J CrossAlicia K HeathTim WaterboerDavid J HughesPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2020)
Biological mechanisms for a potential causal role of H. pylori in colorectal carcinogenesis need to be elucidated, and subsequently whether H. pylori eradication may decrease colorectal cancer incidence.